Industry Focus

Up over 70% in the past year, the iconic newspaper has enjoyed a major boost in readership thanks to the current presidential administration. Meanwhile, Blue Apron struggles to build momentum as meal kit rival HelloFresh prepares for its IPO.

Thanks to Freshbooks for supporting the Motley Fool.  Get a 30-day free trial by going to FreshBooks.com/FOOL and enter “MOTLEY FOOL” in the “How Did You Hear About Us?” section.

Direct download: 20171024_IF_ConsGoods.mp3
Category:Podcast -- posted at: 3:51pm EST

Financials takes a look at bank earnings, important metrics, and catalysts that could move bank stocks higher.

Direct download: 20171023_IF_Financials.mp3
Category:Podcast -- posted at: 3:30pm EST

We wrap up pitch week with discussions of IBM, Netflix, and Mindbody. If you want the whole list of pitch week stocks, email industryfocus@fool.com!

Direct download: 20171020_IF_Tech.mp3
Category:Podcast -- posted at: 3:30pm EST

Three Motley Fool contributors pitch General Motors, NV5, and Transocean as stocks investors might want to watch.

Direct download: 20171019_IF_Energy.mp3
Category:Podcast -- posted at: 3:30pm EST

Novocure, Precision Medicine, and Celgene are three top healthcare stocks. The team discusses their business models and biggest risks in this edition of “Pitch Week.”

Direct download: 20171018_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST

“Pitch Week” continues on Industry Focus as our Foolish contributors share their takes on Under Armour, Dave & Buster’s, and Tractor Supply Co.

Thanks to Harry’s for supporting the Motley Fool. Get your free trial set -- go to Harrys.com/fool.

Direct download: 20171017_IF_ConsumerGoods.mp3
Category:Podcast -- posted at: 3:30pm EST

We kick off "Pitch Week" with a look at payment companies Mastercard and Square, and wrap the show with a breakdown of why Warren Buffett's Berkshire Hathaway has been such a good business to own.

Direct download: 20171016_IF_Financials.mp3
Category:Podcast -- posted at: 3:30pm EST

Netflix got a nice bump after announcing price increases to several of its service tiers – what might the increases mean for the company’s top line and what should investors be paying attention to ahead of the company’s earnings report next week?

Direct download: 20171013_IF_Tech.mp3
Category:Podcast -- posted at: 3:30pm EST

The U.S. has a huge number of investment opportunities in the well-developed energy industry. We discuss why the U.S. oil and gas sector has developed the way it has, some complexities in investing in overseas energy companies, and a few stocks with foreign flare you might want to consider.

Direct download: 20171012_IF_Energy.mp3
Category:Podcast -- posted at: 3:30pm EST

Mylan launches a generic "at-risk" and Flexion's big drug opportunity becomes clearer.

Editor's note: Mylan's drug was mistakenly referred to in the episode as a biosimilar. Copaxone, however, was approved under an NDA, not a BLA, so Mylan's copycat is a generic, not a biosimilar.

Direct download: IF_Healthcare-taylor.mp3
Category:Podcast -- posted at: 3:30pm EST